Exscientia
Exscientia is a technology-driven company focused on AI drug discovery. Their approach combines artificial intelligence with drug design to improve the efficiency and effectiveness of drug development.
- drug design
- AI drug discovery
- precision medicine
- target identification
Locations
Competitors
Nucleome Therapeutics is a biotechnology company focused on decoding the regulatory genome to develop first-in-class precision medicines.
Sygnature Discovery is a world-leading integrated drug discovery and non-clinical solutions provider, offering expertise across a broad range of therapeutic areas and biological target classes.
Alchemab Therapeutics is dedicated to harnessing the power of the immune system to develop innovative antibody therapeutics for hard-to-treat diseases.
Engitix is a fast-growing biotechnology company located at White City Place, a new life sciences cluster in London, UK.
Company Details
Exscientia is operated by Exscientia Limited and is a Active company incorporated on 29 June 2021 with the registered office located in London, Greater London. Exscientia Limited was registered 4 years ago.
Status
Active
Size
Large
Directors
10
Age
4 years old
Employees
501
Turnover
£20.08M
Total Assets
£510.72M
Cash in Bank
£259.46M
Total Liabilities
-£155M
Teams
96
30
24
14
5
5
1
Vice President
Executive Director • Joined Apr 2021
Chief Financial Officer (CFO), Board Member / Executive Director
Executive Director, Head Of Clinical Operations • Joined Nov 2021
Director, Engagement Lead • Joined Dec 2023
Non Executive Director • Joined Jan 2019
Associate Director, Lead Software Engineer • Joined May 2020
Chief People Officer • Joined Aug 2022
Chief AI Officer • Joined Jan 2022
Chief Technology Officer • Joined Nov 2020
Vice President
Executive Director • Joined Apr 2021
Director, Engagement Lead • Joined Dec 2023
Non Executive Director • Joined Jan 2019
Chief People Officer • Joined Aug 2022
Chief AI Officer • Joined Jan 2022
Chief Technology Officer • Joined Nov 2020
Chief Of Staff • Joined May 2022
Associate Director • Joined Jan 2023
Associate Director • Joined Feb 2024
Project Manager • Joined Jun 2021
Project Manager • Joined Dec 2021
Head Of Quality • Joined Apr 2023
Senior CRO Manager • Joined Sep 2023
Director Computational Drug Designer • Joined Jan 2023
Software Engineer • Joined Mar 2022
Software Engineer • Joined Nov 2020
Software Engineer • Joined Jan 2022
Research Engineer • Joined Oct 2021
Software Engineer • Joined Mar 2022
Head Of Discovery Biology • Joined Jul 2019
Associate Director, Biological Data Science • Joined Jan 2022
Senior Research Engineer • Joined Apr 2024
Senior Cell Biologist • Joined Mar 2021
Research Scientist • Joined May 2022
Senior Structural Bioinformatics Research Scientist • Joined Aug 2022
VP Medicinal Chemistry • Joined Nov 2020
Molecular Biology Scientist • Joined Apr 2022
Protein Scientist • Joined Mar 2021
Biological Data Scientist
Chief AI Officer • Joined Jan 2022
ServiceDesk & Asset Lead • Joined Nov 2023
Finance Assistant • Joined Mar 2025
Investor • Joined Apr 2021
Purchaser • Joined Feb 2024
Senior Logistics Manager • Joined May 2023
Senior Facilities Operations Manager • Joined Sep 2022
Senior Buyer • Joined Jul 2024
Buyer • Joined Aug 2024
Purchaser • Joined Feb 2024
Executive Assistant • Joined Apr 2021
View 96 members